Stock 002365 QIANJIANG YONGAN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Qianjiang Yongan Pharmaceutical Co., Ltd.

Equities

002365

CNE100000LZ9

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
8.3 CNY +3.23% Intraday chart for Qianjiang Yongan Pharmaceutical Co., Ltd. +2.47% -15.13%
Apr. 29 Qianjiang Yongan Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 80 million worth of its shares. CI
Apr. 29 Qianjiang Yongan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Qianjiang Yongan Pharmaceutical Co., Ltd. is a China-based company principally engaged in the manufacture and sales of taurine products. The Company operates through three main segments. The Taurine Products segment is mainly engaged in the research, development, manufacture and sales of taurine products, as well as the manufacture and sales of ethylene oxide. The Food Supplement segment is mainly involved in the research, development, manufacture and sales of dietary supplement, as well as the import and sales of overseas dietary supplement. The Health Field segment is mainly involved in the equity or industrial investment in health-related field.

Number of employees: 887

Sales per Business

CNY in Million2022Weight2023Weight Delta
Taurine
68.1 %
883 60.4 % 662 68.1 % -25.03%
Others
22.7 %
403 27.5 % 221 22.7 % -45.20%
Polycarboxylate Water Reducer, etc.
9.2 %
176 12.1 % 90 9.2 % -49.00%

Sales per region

CNY in Million2022Weight2023Weight Delta
Abroad
58.4 %
680 46.5 % 568 58.4 % -16.46%
China
41.6 %
783 53.5 % 405 41.6 % -48.25%

Managers

Managers TitleAgeSince
Ren Gui Hong CEO
 Chief Executive Officer 41 21-06-27
Yu Xi Wu CHM
 Chairman 63 13-11-11
Sheng Jie Xiong DFI
 Director of Finance/CFO 56 21-06-27
Xu Wu BRD
 Director/Board Member 46 01-06-17
Hong Li Ding BRD
 Director/Board Member 58 12-05-30
Xiu li Zhao IRC
 Investor Relations Contact - -
Tian Yuan Zhang AUD
 Comptroller/Controller/Auditor - -
Xi Quan Fang PRN
 Corporate Officer/Principal 60 13-07-29

Members of the board

Members of the board TitleAgeSince
Yong Chen FOU
 Founder 65 01-06-17
Yu Xi Wu CHM
 Chairman 63 13-11-11
Hong Li Ding BRD
 Director/Board Member 58 12-05-30
Wei Lin Duan BRD
 Director/Board Member 50 15-06-08
Xu Wu BRD
 Director/Board Member 46 01-06-17
Chun Xiang Zhao BRD
 Director/Board Member 46 21-06-27
Ren Gui Hong CEO
 Chief Executive Officer 41 21-06-27
Jian Tao Han BRD
 Director/Board Member 50 21-06-27
Bing Zhang BRD
 Director/Board Member 64 21-06-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 294,682,500 194,903,430 ( 66.14 %) 0 66.14 %

Shareholders

NameEquities%Valuation
Gfund Management Co., Ltd.
0.4977 %
1,205,200 0.4977 % 1 M ¥
GF Fund Management Co., Ltd.
0.2013 %
487,500 0.2013 % 554 721 ¥
Hongde Fund Management Co., Ltd.
0.0561 %
135,900 0.0561 % 154 639 ¥
Bosera Asset Management Co., Ltd.
0.0433 %
104,900 0.0433 % 119 365 ¥
Western Leadbank Fund Management Co., Ltd
0.0413 %
100,000 0.0413 % 113 789 ¥
China Asset Management Co., Ltd.
0.0396 %
96,000 0.0396 % 109 237 ¥
Broad Fund Management Co. Ltd.
0.0329 %
79,600 0.0329 % 90 576 ¥
China Fund Management Co., Ltd.
0.0187 %
45,300 0.0187 % 51 546 ¥
CCB Principal Asset Management Co., Ltd.
0.0152 %
36,900 0.0152 % 41 988 ¥
Everbright PGIM Fund Management Co. Ltd.
0.0108 %
26,100 0.0108 % 29 699 ¥

Company contact information

Qianjiang Yongan Pharmaceutical Co., Ltd.

No. 2 Guangze Avenue Qianjiang Economic Development Zone

433132, Qianjiang

+86 72 8620 2737

http://www.chinataurine.com
address Qianjiang Yongan Pharmaceutical Co., Ltd.(002365)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
QIANJIANG YONGAN PHARMACEUTICAL CO., LTD. Stock Qianjiang Yongan Pharmaceutical Co., Ltd.
-15.13% 338M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+37.78% 723B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+31.46% 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
-3.51% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.94% 331B
ABBVIE INC. Stock AbbVie Inc.
+5.14% 288B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.38% 244B
ROCHE HOLDING AG Stock Roche Holding AG
-4.58% 208B
NOVARTIS AG Stock Novartis AG
+10.23% 210B
AMGEN INC. Stock Amgen Inc.
+9.32% 169B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002365 Stock
  4. Company Qianjiang Yongan Pharmaceutical Co., Ltd.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW